Macrophage inhibitory factor (MIF) gene polymorphisms are associated with disease susceptibility and with circulating MIF levels in active non‐segmental vitiligo in patients from western Mexico

Evolving complexity of MIF signaling

(2019) Stanislovas S. Jankauskas et al.   CELLULAR SIGNALLING

Macrophage migration inhibitory factor as an incriminating agent in vitiligo

(2018) Azza Gaber Antar Farag et al.   ANAIS BRASILEIROS DE DERMATOLOGIA

MIF functional polymorphisms (-794 CATT 5-8 and -173 G>C) are associated with MIF serum levels, severity and progression in male multiple sclerosis from western Mexican population

(2018) V.A. Castañeda-Moreno et al.   JOURNAL OF NEUROIMMUNOLOGY

Macrophage Migration Inhibitory Factor -173 G/C Polymorphism: A Global Meta-Analysis across the Disease Spectrum

(2018) Oscar Illescas et al.   Frontiers in Genetics

Oxidative stress drives CD8 + T-cell skin trafficking in patients with vitiligo through CXCL16 upregulation by activating the unfolded protein response in keratinocytes

(2017) Shuli Li et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Misbalanced CXCL12 and CCL5 Chemotactic Signals in Vitiligo Onset and Progression

(2017) Ahmed F. Rezk et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

New discoveries in the pathogenesis and classification of vitiligo

(2017) Michelle Rodrigues et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Updated evidence-based (S2e) European Dermatology Forum guideline on topical corticosteroids in pregnancy

(2017) C.-C. Chi et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Macrophage Migration Inhibitory Factor: A Novel Inhibitor of Apoptosis Signal-Regulating Kinase 1–p38–Xanthine Oxidoreductase–Dependent Cigarette Smoke–Induced Apoptosis

(2016) Jonathan Fallica et al.   AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY

Effectiveness and safety of topical tacrolimus monotherapy for repigmentation in vitiligo: a comprehensive literature review

(2016) Andrea Sisti et al.   ANAIS BRASILEIROS DE DERMATOLOGIA

Macrophage Migration Inhibitory Factor Secretion Is Induced by Ionizing Radiation and Oxidative Stress in Cancer Cells

(2016) Yashi Gupta et al.   PLoS One

Maintenance Therapy of Adult Vitiligo with 0.1% Tacrolimus Ointment: A Randomized, Double Blind, Placebo–Controlled Study

(2015) Marine Cavalié et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Functional polymorphisms in the gene encoding macrophage migration inhibitory factor (MIF) are associated with active pulmonary tuberculosis

(2015) Shou-Gang Kuai et al.   Infectious Diseases

Vitiligo

(2015) Mauro Picardo et al.   Nature Reviews Disease Primers

Macrophage Migration Inhibitory Factor Is a Novel Determinant of Cigarette Smoke–Induced Lung Damage

(2014) Jonathan Fallica et al.   AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY

Macrophage migration inhibitory factor: Association of −794 CATT5–8 and −173 G>C polymorphisms with TNF-α in systemic lupus erythematosus

(2014) U. De la Cruz-Mosso et al.   HUMAN IMMUNOLOGY

Macrophage migration inhibitory factor (MIF): Genetic evidence for participation in early onset and early stage rheumatoid arthritis

(2013) M.A. Llamas-Covarrubias et al.   CYTOKINE

Vitiligo: interplay between oxidative stress and immune system

(2013) Naresh C. Laddha et al.   EXPERIMENTAL DERMATOLOGY

A proliferation-inducing ligand in atopic dermatitis and vitiligo

(2013) Zeinab A. Ibrahim et al.   INTERNATIONAL JOURNAL OF DERMATOLOGY

World Medical Association Declaration of Helsinki

(2013)   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Topical Calcineurin Inhibitors for Atopic Dermatitis: Review and Treatment Recommendations

(2013) Warner W. Carr   PEDIATRIC DRUGS

Macrophage migration inhibitory factor as an incriminating agent in dermatological disorders

(2013) Amir Feily et al.   INDIAN JOURNAL OF DERMATOLOGY

Relationship of macrophage migration inhibitory factor levels in PBMCs, lesional skin and serum with disease severity and activity in vitiligo vulgaris

(2012) Lei Ma et al.   BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH

Revised classification/nomenclature of vitiligo and related issues: the Vitiligo Global Issues Consensus Conference

(2012) K. Ezzedine et al.   Pigment Cell & Melanoma Research

Dual effect of the macrophage migration inhibitory factor gene on the development and severity of human systemic lupus erythematosus

(2011) Antoine Sreih et al.   ARTHRITIS AND RHEUMATISM

A functional microsatellite of the macrophage migration inhibitory factor gene associated with meningococcal disease

(2011) Pascal Renner et al.   FASEB JOURNAL

Serum levels of macrophage migration inhibitory factor are associated with rheumatoid arthritis course

(2011) Mara Anaís Llamas-Covarrubias et al.   RHEUMATOLOGY INTERNATIONAL

Macrophage migration inhibitory factor (MIF): A promising biomarker

(2010) G. Grieb et al.   DRUG NEWS & PERSPECTIVES

Macrophage migration inhibitory factor in patients with vitiligo and relationship between duration and clinical type of disease

(2009) G. Serarslan et al.   CLINICAL AND EXPERIMENTAL DERMATOLOGY

MIF(Macrophage Migration Inhibitory Factor) Promoter Polymorphisms and Susceptibility to Severe Malarial Anemia

(2009) Gordon A. Awandare et al.   JOURNAL OF INFECTIOUS DISEASES

Autoimmune Destruction of Skin Melanocytes by Perilesional T Cells from Vitiligo Patients

(2009) Jasper G. van den Boorn et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Urine macrophage migration inhibitory factor (MIF) in children with urinary tract infection: a possible predictor of acute pyelonephritis

(2008) Hasan Otukesh et al.   PEDIATRIC NEPHROLOGY